Skip to content

Clinical trials

Completed Phase 2 Scleroderma, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2 Status: Completed Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20041
20051
20062
20073
20082
20092
20102
20114
20121
20132
20143
20152
20163
20173
20194
20203
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital for Special Surgery, New York3
Fred Hutchinson Cancer Center2
ISDIN2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
Michael Roth2
Northwestern University2
Sanofi2
Actelion1
Active Biotech AB1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic48
Scleroderma, Diffuse15
Raynaud Disease5
Connective Tissue Diseases4
Lung Diseases, Interstitial4
Arthritis2
Pain2
Rare Diseases2
Skin Diseases2
Aortic Arch Syndromes1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.